What's in a name? From PCOS to polyendocrine metabolic ovarian syndrome: A metabolic reframing, promise, controversies, and challenges ahead - PubMed
3 hours ago
- #PCOS
- #Metabolic Syndrome
- #Medical Nomenclature
- PCOS is being renamed to polyendocrine metabolic ovarian syndrome (PMOS) through a global consensus.
- The new name aims to shift focus from ovarian cysts to broader endocrine and metabolic aspects of the syndrome.
- The renaming process involves 56 organizations and aims to improve diagnostic accuracy and reduce stigma.
- PMOS emphasizes metabolic features like insulin resistance, dysglycemia, and cardiovascular risk.
- Challenges include implementation, infrastructure needs, and controversies over the name change.
- The editorial parallels this change with the transition from NAFLD to MASLD.